Cargando…

Evaluation of cardiovascular risk in a lung cancer screening cohort

INTRODUCTION: Lung cancer screening (LCS) by low-dose computed tomography (LDCT) offers an opportunity to impact both lung cancer and coronary heart disease mortality through detection of coronary artery calcification (CAC). Here, we explore the value of CAC and cardiovascular disease (CVD) risk ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruparel, Mamta, Quaife, Samantha L, Dickson, Jennifer L, Horst, Carolyn, Burke, Stephen, Taylor, Magali, Ahmed, Asia, Shaw, Penny, Soo, May-Jan, Nair, Arjun, Devaraj, Anand, O'Dowd, Emma Louise, Bhowmik, Angshu, Navani, Neal, Sennett, Karen, Duffy, Stephen W, Baldwin, David R, Sofat, Reecha, Patel, Riyaz S, Hingorani, Aroon, Janes, Sam M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Lung Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902068/ https://www.ncbi.nlm.nih.gov/pubmed/31558626 http://dx.doi.org/10.1136/thoraxjnl-2018-212812

Ejemplares similares

Lung Screen Uptake Trial: results from a single lung cancer screening round
por: Ruparel, Mamta, et al.
Publicado: (2020)

Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort
por: Ruparel, Mamta, et al.
Publicado: (2020)

Defining the information needs of lung cancer screening participants: a qualitative study
por: Ruparel, Mamta, et al.
Publicado: (2019)

Reply to Wilson: Improving Lung Cancer Screening Uptake
por: Quaife, Samantha L., et al.
Publicado: (2020)

Psychological outcomes of low-dose CT lung cancer screening in a multisite demonstration screening pilot: the Lung Screen Uptake Trial (LSUT)
por: Kummer, Sonja, et al.
Publicado: (2020)

The role of computer-assisted radiographer reporting in lung cancer screening programmes
por: Hall, Helen, et al.
Publicado: (2022)

Impact of radiographer immediate reporting of X-rays of the chest from general practice on the lung cancer pathway (radioX): a randomised controlled trial
por: Woznitza, Nick, et al.
Publicado: (2023)

Prevalence and clinical characteristics of non-malignant CT detected incidental findings in the SUMMIT lung cancer screening cohort
por: Tisi, Sophie, et al.
Publicado: (2023)

Pulmonary nodules and CT screening: the past, present and future
por: Ruparel, M, et al.
Publicado: (2016)

The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and ‘hard-to-reach’ patients
por: Quaife, Samantha L., et al.
Publicado: (2016)

Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial
por: Brain, Kate, et al.
Publicado: (2017)

Association of Smoking, Alcohol Consumption, Blood Pressure, Body Mass Index, and Glycemic Risk Factors With Age-Related Macular Degeneration: A Mendelian Randomization Study
por: Kuan, Valerie, et al.
Publicado: (2021)

Impact of radiographer immediate reporting of chest X-rays from general practice on the lung cancer pathway (radioX): study protocol for a randomised control trial
por: Woznitza, Nick, et al.
Publicado: (2017)

Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial
por: Brain, Kate, et al.
Publicado: (2016)

Translating genomics into improved healthcare
por: Hingorani, Aroon D, et al.
Publicado: (2010)

What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK?
por: O'Dowd, Emma L, et al.
Publicado: (2015)

Preferences for Decision Control among a High-Risk Cohort Offered Lung Cancer Screening: A Brief Report of Secondary Analyses from the Lung Screen Uptake Trial (LSUT)
por: Bonfield, Stefanie, et al.
Publicado: (2023)

Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review
por: Hall, Helen, et al.
Publicado: (2022)

External validation of a convolutional neural network artificial intelligence tool to predict malignancy in pulmonary nodules
por: Baldwin, David R, et al.
Publicado: (2020)

Performance of polygenic risk scores in screening, prediction, and risk stratification: secondary analysis of data in the Polygenic Score Catalog
por: Hingorani, Aroon D, et al.
Publicado: (2023)

Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)
por: Taylor, Sally, et al.
Publicado: (2021)

The Accuracy of Clinical Staging of Stage I-IIIa Non-Small Cell Lung Cancer: An Analysis Based on Individual Participant Data
por: Navani, Neal, et al.
Publicado: (2019)

Mapping the spectrum of psychological and behavioural responses to low‐dose CT lung cancer screening offered within a Lung Health Check
por: Kummer, Sonja, et al.
Publicado: (2020)

The person behind the nodule: a narrative review of the psychological impact of lung cancer screening
por: Quaife, Samantha L., et al.
Publicado: (2021)

UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer
por: Baldwin, D R, et al.
Publicado: (2011)

Cell migration leads to spatially distinct but clonally related airway cancer precursors
por: Pipinikas, Christodoulos P, et al.
Publicado: (2014)

Could NICE guidance on the choice of blood pressure lowering drugs be simplified?
por: Sofat, Reecha, et al.
Publicado: (2012)

Navigating Diagnostic and Treatment Decisions in Non‐Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach
por: Popat, Sanjay, et al.
Publicado: (2020)

UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening
por: Field, J K, et al.
Publicado: (2016)

Use of systemic anti-cancer treatments in advanced stage non-small cell lung cancer during the SARS-CoV-2 pandemic in England and Wales: an analysis of the Rapid Cancer Registration Dataset
por: Morgan, Helen, et al.
Publicado: (2022)

Smokers’ interest in a lung cancer screening programme: a national survey in England
por: Quaife, Samantha L., et al.
Publicado: (2018)

The impact of COVID-19 on lung cancer diagnostics – a multicentre comparison of 2019/2020 data
por: Navani, Neal, et al.
Publicado: (2021)

Quantifying the impact of Covid-19 on lung cancer: an urgent need for restoration
por: O’Dowd, Emma, et al.
Publicado: (2021)

Telephone risk-based eligibility assessment for low-dose CT lung cancer screening
por: Dickson, Jennifer L, et al.
Publicado: (2022)

Reliable EGFR mutation testing in ultrasound-guided supraclavicular lymph node fine-needle aspirates: a cohort study with diagnostic performance analysis
por: Awwad, Amir, et al.
Publicado: (2015)

The development of the COVID-19 radiological learning system (CORALS ) to improve accurate management in the COVID-19 pandemic
por: Chen, Yan, et al.
Publicado: (2020)

Participation in lung cancer screening
por: Baldwin, David R., et al.
Publicado: (2021)

Circulating Apolipoprotein E Concentration and Cardiovascular Disease Risk: Meta-analysis of Results from Three Studies
por: Sofat, Reecha, et al.
Publicado: (2016)

New fissure-attached nodules in lung cancer screening: more practical implications from the NELSON study?
por: Morgan, Helen, et al.
Publicado: (2020)

Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma
por: Sage, Elizabeth K, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ps7u782sffmibdcmg50nac7rqu